Method of treating a viral infection by administering a steroid compound
June 9, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3016390 3370070 Method and reagents for measuring the level of conjugated bile acids Nondenaturing zwitterionic detergents Process for production of chenodeoxycholic acid New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same Chemical synthesis Ligand analog-irreversible enzyme inhibitor conjugates Sodium salt of ursodeoxycholic sulphate Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments InventorAssigneeApplicationNo. 479457 filed on 06/07/1995US Classes:514/169, Cyclopentanohydrophenanthrene ring system DOAI514/170, Plural Compounds containing cyclopentanohydrophenanthrene ring systems514/171, With additional active ingredient514/172, Hetero ring containing514/173, Spiro ring system514/174, -O-C-O- is part of a hetero ring (e.g., acetonide, etc.)514/175, -C(=O)-O-is part of a hetero ring (e.g., lactone, etc.)514/176, Nitrogen containing hetero ring514/177, Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/178, Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/179, Modified C-ring (except methyl in 13-position) (e.g., double bond containing, substituted, etc.)514/180, 9-position substituted514/181, 21-position substituted514/182Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring systemExaminersPrimary: Prior, Kimberly J.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/56A61K 031/565 A61K 031/57 A61K 031/58 AbstractA method of treating a viral infection includes administering an effective amount of a compound having the following structure: ##STR1## or a pharmaceutically acceptable salt thereof. This compound treats the viral infection by suppressing the growth of a viral target cell. As one specific example, this compound may be used to treat HIV infection.Other References
Field of SearchCyclopentanohydrophenanthrene ring system DOAIPlural Compounds containing cyclopentanohydrophenanthrene ring systems With additional active ingredient Hetero ring containing Spiro ring system -O-C-O- is part of a hetero ring (e.g., acetonide, etc.) -C(=O)-O-is part of a hetero ring (e.g., lactone, etc.) Nitrogen containing hetero ring Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system Modified C-ring (except methyl in 13-position) (e.g., double bond containing, substituted, etc.) 9-position substituted 21-position substituted Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system | |
